Microneedle patch and preparation method and application thereof

By introducing a mesoporous outer layer and a soluble inner layer structure into the microneedle patch, combined with sustained-release microcapsules, the problem of the inability of existing microneedles to release drugs is solved, achieving long-term slow release of drugs, which is suitable for the treatment of chronic diseases.

CN122398710APending Publication Date: 2026-07-17HUNAN AGRI UNIV ANIMAL PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
HUNAN AGRI UNIV ANIMAL PHARMA
Filing Date
2026-05-12
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

Existing solid microneedles, hollow microneedles, coated microneedles, and soluble microneedles cannot achieve sustained drug release. In particular, soluble microneedles separate rapidly after being inserted into the skin, resulting in rapid drug delivery in a short period of time, which cannot meet the treatment needs of long-term medication or treatment with large fluctuations in drug concentration.

Method used

The microneedle patch design employs a mesoporous outer layer and a soluble inner layer structure. The mesoporous outer layer serves as the support structure for the microneedles and the drug release channel, while the inner layer contains sustained-release microcapsules. The slow release of the drug is restricted through the channels of the mesoporous outer layer, thereby achieving long-acting drug delivery.

Benefits of technology

It achieves slow drug release, making it suitable for long-term medication or treatment of chronic diseases with large fluctuations in drug concentration, thus improving drug efficiency and effectiveness.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122398710A_ABST
    Figure CN122398710A_ABST
Patent Text Reader

Abstract

本发明属于微针贴片技术领域,具体涉及一种微针贴片及其制备方法和应用。其中,微针贴片中,微针的结构包括介孔外层和可溶性内层;所述介孔外层中,介孔的平均孔径为200nm~500nm;所述可溶性内层的制备原料包括缓释微胶囊。介孔外层既作为微针支撑结构,防止微针因受挤压而变形,又提供了药物释放通道;可溶性内层中包含了缓释微胶囊,将药物缓慢释放,再通过介孔外层的通道限制,使药物进一步缓释,达到长效微针的作用。
Need to check novelty before this filing date? Find Prior Art